REQUEST A DEMO
Total
USD $0.00
Search more companies

Oncogenerika Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Oncogenerika Sp. z o.o. Profile Updated: December 26, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Oncogenerika Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. Oncogenerika Sp. z o.o. was incorporated on April 22, 2005. Oncogenerika Sp. z o.o. currently employs 20 (2006) people. Its’ total assets recorded a growth of 77.55%.

Headquarters
Ul. Foksal 16
Warsaw; Mazowieckie; Postal Code: 00-372

Contact Details: Purchase the Oncogenerika Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Oncogenerika Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Oncogenerika Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Oncogenerika Sp. z o.o. report to view the information.
Incorporation Date:
April 22, 2005
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Oncogenerika Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
911878.42%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
77.55%
Total equity
81.16%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?